1. Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions. (28th October 2014) Authors: Peris, K.; Stockfleth, E.; Gupta, G.; Aractingi, S.; Dakovic, R.; Dirschka, T.; Alomar, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 12(2015:Dec.) Page Start: 2470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Imiquimod 3.75% in actinic keratosis: efficacy in patients with and without rest periods during treatment. (24th August 2015) Authors: Dirschka, T.; Peris, K.; Gupta, G.; Alomar, A.; Aractingi, S.; Dakovic, R.; Stockfleth, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 8(2016:Aug.) Page Start: 1416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term sustained lesion clearance from Lmax with imiquimod 3.75%, a new field‐directed treatment for actinic keratosis. (29th August 2014) Authors: Gupta, G.; Stockfleth, E.; Peris, K.; Aractingi, S.; Alomar, A.; Dakovic, R.; Dirschka, T. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 9(2015:Sep.) Page Start: 1840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗